Twenty-six years of chasing New York City sex crimes as the face of “Law & Order: Special Victims Unit” has prepared ...
Bristol Myers Squibb’s mezigdomide has scored its first phase 3 win, with the Cereblon E3 ligase modulator (CELMoD) tied to a statistically significant improvement in progression-free survival (PFS) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results